BGNE - BeiGeneAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $280.65 | Open | $279.77 |
| Volume | 233.6K | Market Cap | 25.529B |
| Yield | Last Dividend |
| The Daily Biotech Pulse: FDA Nod For Pfi... | 6:47 AM |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28) 10... | |
| Leap Therapeutics and BeiGene Announce F... | 09/21/20 |
| CAMBRIDGE, Mass. and BEIJING, Sept. 21, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targ... | |
| BeiGene Presents Data at ESMO Virtual Co... | 09/17/20 |
| CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene presents Phase 3 data of tislelizumab in non-squamous non-small cell lung cancer ... | |
| The Daily Biotech Pulse: Moderna Inks 2 ... | 09/17/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Ar... | |
| The Daily Biotech Pulse: Moderna Expands... | 09/16/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Avidity Biosciences Inc (NASDAQ: RNA ) Beigene Ltd (NASDAQ: BGNE ) Bicycle Therapeut... | |
| BeiGene to Present at the Morgan Stanley... | 09/10/20 |
| CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $bgne #beigene--BeiGene announced that the Company will present at the Morgan Stanley 18th Annual Glob... | |
| BeiGene Announces Acceptance and Priorit... | 09/09/20 |
| CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BGNE--Health Canada accepted BeiGene's New Drug Submission for BRUKINSA?? (zanubrutinib) in Wal... | |
| BeiGene Announces Inclusion of Its Share... | 09/04/20 |
| BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene announces inclusion in Shanghai-Hong Kong Stock Connect and inclusion in Hang Sen... | |
| BeiGene : China's BeiGene to start human... | 08/27/20 |
| China-based drugmaker BeiGene Ltd said on Thursday that an early-stage human study to test its COVID-19 antibody treatment will begin in September. | ... | |
| BeiGene : VOLUNTARY ANNOUNCEMENT - UPDAT... | 08/25/20 |
| Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, mak... | |
| BeiGene Appoints Corsee Sanders, Ph.D. t... | 08/25/20 |
| CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)---- $BGNE #BGNE--BeiGene appoints Corsee Sanders, Ph.D. to the Board of Directors. | |
| Bio-Thera Solutions and BeiGene Announce... | 08/24/20 |
| GUANGZHOU & BEIJING & CAMBRIDGE, Mass--(BUSINESS WIRE)---- $BGNE--Bio-Thera Solutions and BeiGene announce license, distribution, and supply agreement... | |
| BeiGene : Next Day Disclosure Return | M... | 08/11/20 |
| For Main Board listed issuers Next Day Disclosure Return Name of listed issuer: _BeiGene, Ltd. ??? | August 12, 2020 | |
| BeiGene Reports Second Quarter 2020 Fina... | 08/06/20 |
| CAMBRIDGE, Mass. and BEIJING, China, Aug. 06, 2020 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology??? | |
| The Daily Biotech Pulse: Aurinia's Kidne... | 07/22/20 |
| Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) ABIOMED, Inc. (NASDAQ: ABMD ) Assembly Biosciences Inc (NASDAQ: ASMB ) Bio-Rad Labora... | |
| The Daily Biotech Pulse: Opko Wins CDC C... | 07/21/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Abb... | |
| Assembly Biosciences : Signs Deal With B... | 07/20/20 |
| By Chris Wack Assembly Biosciences Inc. shares were up 7% to $26.01 after it entered into a collaboration with BeiGene Ltd. in China for Assembly's po... | |
| BeiGene, Assembly Bio Ink $540M China HB... | 07/20/20 |
| BeiGene (BGNE) and Assembly Biosciences (ASMB) have announced a new collaboration in China for Assembly???s three clinical-stage core inhibitor candid... | |
| Assembly Biosciences and BeiGene Announc... | 07/20/20 |
| -- BeiGene acquires exclusive development and commercialization rights to ABI-H0731, ABI-H2158, and ABI-H3733 in China ---- Assembly receives $40 mill... | |
| The Daily Biotech Pulse: Mallinckrodt Ge... | 07/16/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) Ato... | |
| The Daily Biotech Pulse: Moderna To Kick... | 07/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alt... | |
| The Daily Biotech Pulse: Blueprint, Roch... | 07/14/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Alt... | |
| Amgen Pours A Further $421M Into China??... | 07/13/20 |
| Amgen (AMGN) has announced an additional investment of approximately $421 million in BeiGene???s (BGNE) registered direct offering of ordinary shares.... | |
| BeiGene, once a target for short sellers... | 07/13/20 |
| China???s red-hot pharmaceutical and biotechnology sector is drawing in billions of dollars from US investors.No example is more surprising than the w... | |
| HK, Nasdaq-listed Chinese biotech firm B... | 07/13/20 |
| Beigene is backed by Amgen Ventures, GIC, and Asia-focused PE major Hillhouse Capital. The post HK, Nasdaq-listed Chinese biotech firm BeiGene to rais... | |
| BeiGene Plans $2B Direct Offering; Analy... | 07/13/20 |
| Chinese biotech BeiGene (BGNE) has announced the pricing of a registered direct offering of 145,838,979 ordinary shares, par value $0.0001 per share t... | |
| Amgen Announces Additional Investment In... | 07/12/20 |
| Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares,... | |
| BeiGene to Raise US$2.07 Billion via Sha... | 07/12/20 |
| By P.R. Venkat BeiGene Ltd. is planning to raise US$2.07 billion in net proceeds from a share issuance in order to expand its business and meet workin... | |
| Chi-Med, BeiGene Join Forces For Solid C... | 05/26/20 |
| Hutchison China MediTech (HCM) and BeiGene (BGNE) have now entered into a clinical collaboration agreement for the treatment of various solid tumor ca... | |
| An expert tech investor beating 97% of h... | 04/29/20 |
| Randall Dishmon manages the Invesco Oppenheimer Global Focus Fund, which is delivering positive returns and beating 97% of its competition this year. ... | |
| Strong Buy rating | 08/10/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $235.00 to $241.00 | |
| Strong Buy rating | 07/15/20 |
| Morgan Stanley maintains Overweight rating and raises Price Target from $190.00 to $235.00 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| AungPan Thar's Swing trading | Kyaw Aung | 65.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
